Company news
Bide Pharmatech Co. Ltd. Class A (SSE:688073) news
Bide Pharmatech Co. Ltd. Class A news releases on 6ix. Latest, Sep 28, 2026: (688073)"BIDE PHARMATECH CO., LTD."Announcement on Use of Surplus Raised Funds…
Press releases & updates
(688073)"BIDE PHARMATECH CO., LTD."Announcement on Use of Surplus Raised Funds and Remaining Over-raised Funds to Permanently Supplement Working Capital
September 27, 2026
(688073)"BIDE PHARMATECH CO., LTD."Announcement on Election of New Board of Directors
September 27, 2026
"BIDE PHARMATECH CO., LTD."Notice on Convening the 3rd Extraordinary General Meeting in 2026
September 27, 2026
"BIDE PHARMATECH CO., LTD."Announcement on Expiration of Shareholding Reduction Plan by Shareholder and Results of Shareholding Reduction
September 9, 2026
"BIDE PHARMATECH CO., LTD."Announcement on the Vesting Results for the First Vesting Period of the Initial Grant and Reserved Grant under the 2024 Restricted Share Incentive Plan
September 7, 2026
"BIDE PHARMATECH CO., LTD."Announcement on Provision for Asset Impairment for the First Half of 2026
August 27, 2026
"BIDE PHARMATECH CO., LTD."Announcement on Shareholding Reduction Plan of Shareholder
August 24, 2026
"BIDE PHARMATECH CO., LTD."Indicative Announcement on Shareholder's Equity Change Reaching an Integer Multiple of 5%
August 12, 2026
"BIDE PHARMATECH CO., LTD."Announcement on Abnormal Fluctuations in Stock Trading
August 10, 2026
"BIDE PHARMATECH CO., LTD."Indicative Announcement on the Expiration and Non-Renewal of the Concerted Action Agreement among the Actual Controllers and No Change in the Actual Controllers
August 6, 2026
"BIDE PHARMATECH CO., LTD."Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
July 16, 2026
"BIDE PHARMATECH CO., LTD."Indicative Announcement on Shareholders' Equity Change Reaching the 1% Threshold
July 8, 2026
"BIDE PHARMATECH CO., LTD."Announcement on Renewing Engagement of Audit Institution for 2026
June 30, 2026
Announcement on Resignation of Secretary of the Board of Directors
June 17, 2026
Indicative Announcement on Shareholder's Equity Change Reaching 1% Scale
June 12, 2026
Announcement on Implementation of Dividend Distribution for 2025
June 3, 2026
Announcement on Shareholding Reduction Plan for Shareholders
May 18, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 13, 2026
Report for Q1 2026
April 29, 2026
Announcement on Expiration of Shareholding Reduction Plan for Shareholders and Results of Shareholding Reduction
April 28, 2026
Announcement on 2025 Annual Profit Distribution Plan
April 22, 2026
Announcement on Completion of Shareholding Reduction Plan by Shareholder and Results of Share Reduction
April 7, 2026
Announcement on Listing and Circulation of Partial Restricted Shares in Initial Public Offering
April 2, 2026
Announcement on Using Self-owned Funds to Pay Funds Required for Investment Projects Financed by Raised Funds and Replacing Them with an Equal Amount of Raised Funds
March 9, 2026
Announcement on Preliminary Earnings Estimate for 2025
February 27, 2026
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
February 9, 2026
Notice on Convening the 1st Extraordinary General Meeting in 2026
January 23, 2026
Announcement on Supplementary Confirmation of Daily Related Party Transactions in 2025
January 5, 2026
Indicative Announcement on Change in Shareholder's Equity Reaching an Integer Multiple of 5%
December 22, 2025
Announcement on Resolutions of the 5th Extraordinary General Meeting in 2025
December 10, 2025
Announcement on the By-election of Non-independent Directors
November 24, 2025
Announcement on Convening the Q3 2025 Performance Briefing
November 19, 2025
Indicative Announcement on Shareholder's Equity Change Reaching 1%
November 14, 2025
Report for Q3 2025
October 29, 2025
Announcement on Planning to Conduct Foreign Exchange Hedging Business
October 15, 2025
Announcement on Correction of 2025 Semi-annual Report
September 12, 2025
Announcement on Completing Industrial and Commercial Change and Obtaining Business Licenses
September 2, 2025
Announcement on Making Provisions for Asset Impairment for the Half-Year Period of 2025
August 21, 2025
Announcement on Resignation of Director and Election of Employee Director
August 15, 2025
Announcement on Resolutions of the 4th Extraordinary General Meeting in 2025
July 31, 2025
Notice on Convening the 4th Extraordinary General Meeting in 2025
July 15, 2025
Announcement on Adjusting Upper Limit of Repurchase Price after Implementation of Dividend Distribution for 2024
July 2, 2025
Announcement on Progress in Repurchasing Shares
June 4, 2025
Announcement on Implementation of Dividend Distribution for 2024
June 2, 2025
Announcement on Appointment of Secretary of the Board of Directors
May 19, 2025
Announcement on Shares Repurchased through Call Auction Reaching 2% of the Company's Share Capital and Repurchase Progress
May 16, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 14, 2025
Announcement on Resolutions of the 21st Meeting of the 2nd Board of Directors
April 23, 2025
Announcement on Resolution of the 20th Meeting of the 2nd Board of Directors
April 18, 2025
Announcement on Convening an Investor Briefing regarding the Termination of the Issuance of Shares for Asset Acquisition and the Raising of Supporting Funds
April 16, 2025